Back to search

Polymorphic markers associated with severe oxaliplatin‐induced, chronic peripheral neuropathy in colon cancer patients

Data up to Jan 2025

Published2011
Citations78
References23

Total Citations Per Year

Abstract

References (23)

PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses

2007 • 29,581 citations

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

2000 • 3,785 citations

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

2004 • 3,458 citations

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

2003 • 2,212 citations

The GOA database in 2009--an integrated Gene Ontology Annotation resource

2008 • 552 citations

SMOOTH MUSCLE CONTRACTION AND RELAXATION

2003 • 452 citations

Systemic Therapy for Metastatic Colorectal Cancer: Current Options, Current Evidence

2005 • 317 citations

Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy

2007 • 264 citations

Genome-wide association studies in pharmacogenomics

2010 • 260 citations

SMOOTH MUSCLE CONTRACTION AND RELAXATION

2003 • 239 citations

Pharmacogenetic Assessment of Toxicity and Outcome After Platinum Plus Taxane Chemotherapy in Ovarian Cancer: The Scottish Randomised Trial in Ovarian Cancer

2007 • 233 citations

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

2006 • 203 citations

Clinical Management of Oxaliplatin-Associated Neurotoxicity

2005 • 189 citations

HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene Promoter

2002 • 183 citations

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy

2005 • 171 citations

Predictive Factors of Oxaliplatin Neurotoxicity: The Involvement of the Oxalate Outcome Pathway

2007 • 121 citations

Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

2009 • 120 citations

HMGB1 Interacts with Many Apparently Unrelated Proteins by Recognizing Short Amino Acid Sequences

2002 • 107 citations

Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10

2005 • 75 citations

Cloning of PC3B, a Novel Member of the PC3/BTG/TOB Family of Growth Inhibitory Genes, Highly Expressed in the Olfactory Epithelium

2000 • 66 citations

Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients

2008 • 51 citations

Oxaliplatin-Induced Chronic Peripheral Neurotoxicity: A Prospective Analysis in Patients with Colorectal Cancer

2010 • 41 citations

Non-histone Chromosomal Proteins HMG1 and 2 Enhance Ligation Reaction of DNA Double-Strand Breaks

1998 • 34 citations

Cited By (0)

No citing papers found in database

Polymorphic markers associated with severe oxaliplatin‐induced, chronic peripheral… (2011) – Cancer | Metascience Observatory Explorer